ACO Reporting


ACO Reporting


ACO Name and Location


Genesys PHO, L.L.C.
Previous Names: N/A
3495 S. Center Road
Burton, MI 48519

ACO Primary Contact


Primary Contact NameRobert Brace Reid
Primary Contact Phone Number  (810) 424-2016
Primary Contact Email AddressBrace.Reid@genesyspho.com

Organizational Information


ACO participants:

ACO ParticipantsACO Participant in Joint Venture
GENESYS PRACTICE PARTNERS INCN
SILVER LAKE FAMILY PRACTICE LLCN
EDWARD J LIS JR DO PLLCN
DOUGLAS M IDDINGS PCN
MARCOS MACHADO MD PCN
HEMANT T THAWANI MD PLLCN
David CoriassoN
Edward LisN
WOMENS SPECIALTY ASSOCIATES, P.C.N
UROLOGICAL SERVICES PCN
GRAND BLANC VISION CLINIC PCN
FAMILY EYE CARE CTR PCN
GENESEE HEMATOLOGY ONCOLOGY PCN
GENESYS REGIONAL MEDICAL CENTERY
HENRY HAGENSTEIN DO PCN
Consultants In Ophthalmic & Facial Plastic SurgeryN
FLINT GASTROENTEROLOGY ASSOCIATES PCN
SURGICAL ASSOCIATES, PLCN
GENESEE LUNG ASSOCIATES PCN
ROBERT JAY ZENDLER II DO PCN
FENTON FAMILY MEDICINE PCN
DISKIN DISKIN AND KEOLEIAN PCN
DAVID M. CORIASSO ODN
Tarik WasfieN
SURESH ANNE MD PCN
Ortonville Foot & Ankle Center PcN
SYNTHESIS MEDICAL SPECIALTIES PCN
BRADLEY E HABERMEHL OD PCN
Shiawassee Physician ServicesN
LAPEER MEDICAL ASSOCIATES PCN
CHRISTOPHER D TYKOCKI DO PCN
MICHIGAN GASTROENTEROLOGY CLINIC, PCN
TIMOTHY R HARRIS OD PLCN
BEECHER SURGICAL ASSOCIATES PLLCN
JAWAD A SHAH, MD PCN
Dr. Michael T. Owczarzak P.C.N
VITREORETINAL SPECIALISTS PLCN
M AL JABBAN MD PLCN
LAPEER MEDICAL DIAGNOSTICS PCN
JAMES S GARFIELD DO PCN
MICHAEL D ZERAFA PLLCN
Ascension Medical Group GenesysY


ACO governing body:

MemberMember's
Voting Power
– Expressed
as a percentage
or number
Membership TypeACO Participant
Legal Business
Name/DBA, if
Applicable
Last NameFirst NameTitle/Position
Anderson John1ACO Participant RepresentativeAscension Genesys Hospital
ArnoldDr. JeffreyChair1ACO Participant RepresentativeAscension Medical Group Genesys
BediDr. Dhiraj1ACO Participant RepresentativeAscension Medical Group Genesys
CoriassoDr. RonaldSecretary1ACO Participant RepresentativeAscension Medical Group Genesys
DeSimoneDr. Dennis1ACO Participant RepresentativeAscension Genesys Hospital
HansonDr. Dale1ACO Participant RepresentativeAscension Medical Group Genesys
HaywoodNancy1ACO Participant RepresentativeAscension Genesys Hospital
KommareddiDr. PrasadTreasurer1ACO Participant RepresentativeAscension Medical Group Genesys
PalazzoloChrisVice Chair1ACO Participant RepresentativeAscension Genesys Hospital
RaoDr. Sridhar  1ACO Participant RepresentativeAscension Medical Group Genesys
RosenbaumEdwardPatient Advocate1Community Stakeholder Representative
SilverDr. Mark1ACO Participant RepresentativeAscension Genesys Hospital
WalterDr. James1ACO Participant Representative


Key ACO clinical and administrative leadership:

Randy Kummler  ACO Executive
Sridhar Rao, MD  Medical Director
Robert Brace Reid  Compliance Officer
Marcia Brandt  Quality Assurance/Improvement Officer  


Associated committees and committee leadership:

Committee NameCommittee Leader Name and Position  
Finance, Contracting, Cost Containment CommitteePrasad Kommareddi, MD., Chair
Information Systems CommitteeSridhar Rao, MD, Chair
Clinical Health Informatics CommitteeSridhar Rao, MD, Chair
Quality Improvement & Credentialing CommitteeRene Krusinak, DO, Chair
Specialist Quality Improvement & Credentialing CommitteePaul Adams, MD., Chair
Patient Centered Medical Home Physician Advisory Committee  Dhiraj Bedi, DO, Chair
Preferred Panel Specialist CommitteeLinda Norrell, MD, Chair
Medical Directors CommitteeSridhar Rao, MD, Chair


Types of ACO participants, or combinations of participants, that formed the ACO:
  • ACO professionals in a group practice arrangement
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses


Amount of Shared Savings/Losses
  • Second Agreement Period
    • Performance Year 2018, $5,360,927
  • First Agreement Period
    • Performance Year 2017, $2,800,594
    • Performance Year 2016, $4,540,213
    • Performance Year 2015, $2,154,556
Shared Savings Distribution
  • Second Agreement Period
    • Performance Year 2018
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 90%
  • First Agreement Period
    • Performance Year 2017
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 90%
    • Performance Year 2016
      • Proportion invested in infrastructure: 2.5%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 90%
    • Performance Year 2015
      • Proportion invested in infrastructure: 4.1%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 90%

Quality Performance Results


2018 Quality Performance Results:

ACO#Measure NameRateACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 87.51   86.14
ACO-2 CAHPS: How Well Your Providers Communicate 92.76 92.60
ACO-3 CAHPS: Patients’ Rating of Provider 91.95 92.45
ACO-4 CAHPS: Access to Specialists 84.56 81.50
ACO-5 CAHPS: Health Promotion and Education 58.68 59.26
ACO-6 CAHPS: Shared Decision Making 58.50 61.94
ACO-7 CAHPS: Health Status/Functional Status 72.98 73.35
ACO-34 CAHPS: Stewardship of Patient Resources 24.16 26.26
ACO-8 Risk Standardized, All Condition Readmission 15.09 14.98
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) 19.20 18.59
ACO-36 All-Cause Unplanned Admissions for Patient With Diabetes 38.58 37.01
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 74.00 76.75
ACO-38   All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 57.67 59.00
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 1.60 1.98
ACO-11 Use of Certified EHR Technology 96.60 97.66
ACO-12 Medication Reconciliation 92.64 85.91
ACO-13 Falls: Screening for Future Fall Risk 80.30 79.73
ACO-44 Imaging Studies for Low Back Pain 68.63 64.36
ACO-14 Preventive Care and Screening: Influenza Immunization 68.05 72.71
ACO-15 Pneumonia Vaccination Status for Older Adults 78.66 75.97
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 85.99 76.83
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 75.86 72.81
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 67.84 66.74
ACO-19 Colorectal Cancer Screening 75.00 68.27
ACO-20 Breast Cancer Screening 77.94 71.96
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 75.93 81.47
ACO-40 Depression Remission at Twelve Months 4.11 8.76
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 18.28 15.51
ACO-41 Diabetes: Eye Exam 63.43 52.42
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 74.03 73.10
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 87.11 88.92


Please note, the ACO-36 performance rate has been updated to correct a non-material technical error, as announced in the February 13, 2019 ACO Spotlight newsletter.

Note: In the Quality Performance Results file(s) above, search for “Genesys PHO, L.L.C.” to view the quality performance results. This ACO can also be found by using the ACO ID A14417 in the public use files on data.cms.gov.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Yes, our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR 425.612
  • Waiver for Payment for Telehealth Services:
    • No, our ACO clinicians do not provide telehealth services using the flexibilities under 42 CFR 425.612(f) and 42 CFR 425.613